Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Work In Process (2019 - 2022)

Historic Work In Process for Marimed (MRMD) over the last 4 years, with Q1 2022 value amounting to $4.1 million.

  • Marimed's Work In Process rose 85797.94% to $4.1 million in Q1 2022 from the same period last year, while for Mar 2022 it was $4.1 million, marking a year-over-year increase of 85797.94%. This contributed to the annual value of $4.7 million for FY2021, which is 89513.85% up from last year.
  • According to the latest figures from Q1 2022, Marimed's Work In Process is $4.1 million, which was up 85797.94% from $4.7 million recorded in Q4 2021.
  • Marimed's 5-year Work In Process high stood at $4.7 million for Q4 2021, and its period low was $80476.0 during Q4 2019.
  • Its 4-year average for Work In Process is $1.9 million, with a median of $468377.0 in 2020.
  • Its Work In Process has fluctuated over the past 5 years, first surged by 48200.83% in 2020, then surged by 89513.85% in 2021.
  • Marimed's Work In Process (Quarter) stood at $80476.0 in 2019, then soared by 482.01% to $468377.0 in 2020, then surged by 895.14% to $4.7 million in 2021, then fell by 12.77% to $4.1 million in 2022.
  • Its Work In Process stands at $4.1 million for Q1 2022, versus $4.7 million for Q4 2021 and $3.4 million for Q3 2021.